ATE502305T1 - Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik - Google Patents

Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik

Info

Publication number
ATE502305T1
ATE502305T1 AT05742347T AT05742347T ATE502305T1 AT E502305 T1 ATE502305 T1 AT E502305T1 AT 05742347 T AT05742347 T AT 05742347T AT 05742347 T AT05742347 T AT 05742347T AT E502305 T1 ATE502305 T1 AT E502305T1
Authority
AT
Austria
Prior art keywords
proenkephalin
fragments
amino acids
enkephalins
precursors
Prior art date
Application number
AT05742347T
Other languages
English (en)
Inventor
Andreas Bergmann
Andrea Ernst
Original Assignee
Brahms Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brahms Gmbh filed Critical Brahms Gmbh
Application granted granted Critical
Publication of ATE502305T1 publication Critical patent/ATE502305T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/665—Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • G01N2333/70—Enkephalins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
AT05742347T 2004-05-13 2005-05-11 Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik ATE502305T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04090191 2004-05-13
PCT/EP2005/005090 WO2005114222A1 (en) 2004-05-13 2005-05-11 Use of precursors of enkephalins and/or their fragments in medical diagnostics

Publications (1)

Publication Number Publication Date
ATE502305T1 true ATE502305T1 (de) 2011-04-15

Family

ID=34928803

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05742347T ATE502305T1 (de) 2004-05-13 2005-05-11 Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik

Country Status (7)

Country Link
US (1) US8013123B2 (de)
EP (2) EP2293079B1 (de)
JP (1) JP4976282B2 (de)
AT (1) ATE502305T1 (de)
DE (1) DE602005026931D1 (de)
ES (2) ES2431288T3 (de)
WO (1) WO2005114222A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2208071B1 (de) 2007-10-05 2012-08-01 Becton, Dickinson and Company Verfahren zur diagnose von krankheiten
SG10201704689XA (en) 2008-01-18 2017-07-28 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
AU2011280936A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
KR20130041961A (ko) 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액에서 질환 또는 상태의 특징을 검출하는 방법
EP2596116A4 (de) 2010-07-23 2014-03-19 Harvard College Verfahren zur erkennung von autoimmun- oder autoimmunbezogenen erkrankungen oder leiden
US20150141260A1 (en) 2012-06-15 2015-05-21 Harry Stylli Methods of detecting diseases or conditions using circulating diseased cells
AU2013274002A1 (en) 2012-06-15 2015-02-05 Harry Stylli Methods of detecting diseases or conditions
ES2676737T3 (es) * 2012-10-02 2018-07-24 Sphingotec Gmbh Método para predecir el riesgo de contraer cáncer o para diagnosticar cáncer en un sujeto femenino
TR201809001T4 (tr) * 2012-10-02 2018-07-23 Sphingotec Gmbh Böbrek fonksiyonunu teşhis etmek veya izlemek veya böbrek fonksiyonu bozukluğunu teşhis etmek için bir usul.
CN104937419B (zh) * 2013-01-08 2018-08-10 斯弗因高泰克有限公司 预测受试者患癌症的风险或诊断癌症的方法
EP2965077B1 (de) 2013-03-09 2022-07-13 Harry Stylli Verfahren zur krebserkennung
EP3385717A3 (de) 2013-03-09 2018-10-24 Harry Stylli Verfahren zum nachweis von prostatakrebs
CA2907357A1 (en) * 2013-03-15 2014-09-18 Kinemed, Inc. Biomarkers
EP3191846A4 (de) 2014-09-11 2018-06-13 Harry Stylli Verfahren zum nachweis von prostatakrebs
JP6841765B2 (ja) * 2015-04-24 2021-03-10 シュピーンゴテック ゲゼルシャフト ミット ベシュレンクテル ハフツング 慢性腎疾患の発症のリスクを予測するための方法
JP6651493B2 (ja) * 2017-12-05 2020-02-19 チョンシー ユー ペプチド及び関連化合物の経皮送達システム
WO2022071242A1 (ja) * 2020-09-30 2022-04-07 国立大学法人 長崎大学 腎がん患者の抗がん剤抵抗性および予後予測方法、抗腎がん物質のスクリーニング方法、ならびに、腎がん治療用医薬組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388236A (en) * 1979-08-30 1983-06-14 Hoffmann-La Roche Inc. Enkephalin-like compounds in bovine adrenal medulla
JPS63111465A (ja) * 1986-10-29 1988-05-16 Agency Of Ind Science & Technol ロイシンエンケフアリンのエンザイムイムノアツセイ法
JPH05308992A (ja) * 1992-03-31 1993-11-22 Agency Of Ind Science & Technol モノクローナル抗体
CA2623458A1 (en) * 1999-05-17 2000-11-23 Conjuchem Biotechnologies Inc. Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
CA2311201A1 (en) * 1999-08-05 2001-02-05 Genset S.A. Ests and encoded human proteins
US20030134301A1 (en) * 2001-07-27 2003-07-17 Brooksbank Robert Alan Identification and use of molecules implicated in pain
ITMI20012205A1 (it) * 2001-10-22 2003-04-22 Nanorganics Llc Metodo e mezzi per l'identificazione precoce di rischi di scompenso cardiaco
US20040014143A1 (en) * 2002-05-29 2004-01-22 Haskins William E. Method and apparatus for detecting and monitoring peptides, and peptides identified therewith

Also Published As

Publication number Publication date
ES2363156T3 (es) 2011-07-22
EP1745297B1 (de) 2011-03-16
DE602005026931D1 (de) 2011-04-28
US8013123B2 (en) 2011-09-06
US20080261232A1 (en) 2008-10-23
ES2431288T3 (es) 2013-11-25
EP2293079B1 (de) 2013-08-14
JP4976282B2 (ja) 2012-07-18
EP2293079A2 (de) 2011-03-09
EP1745297A1 (de) 2007-01-24
JP2007537430A (ja) 2007-12-20
WO2005114222A1 (en) 2005-12-01
EP2293079A3 (de) 2011-03-30

Similar Documents

Publication Publication Date Title
ATE502305T1 (de) Verwendung von vorstufen von enkephalinen und/oder deren fragmenten in der medizinischen diagnostik
BRPI0513135A (pt) bibliotecas de polinucleotìdeos, método de produção das mesmas, método de identificação de um polinucleotìdeo, região de ligação, meio adequado para uso em um, dispositivo eletrÈnico e dispositivo
ATE405650T1 (de) Produktion von ganzen antikörpern in prokaryontischen zellen
IS8432A (is) Mótefni sem bindast viðtaka hvítfrumuboða-4
MX2008009886A (es) Anticuerpos que enlazan par-2.
NZ596409A (en) Anti macrophage migration inhibitory factor antibodies
PT1626985E (pt) Gera??o de prote?nas de liga??o artificiais ? base da prote?na ubiquitina
JP2008530138A5 (de)
DE60130538D1 (de) Humanisierte antikörper gegen ccr2 und verfahren zur deren verwendung
BR0315161A (pt) Anticorpo isolado, polinicleotìdeo isolado, vetor, célula hospedeira, método de produzir um anticorpo, e, composição
DE19207796T1 (de) Antigen zur bindung von proteinen an proprotein-konvertase-subtilisin/kexin vom typ 9 (pcsk9)
ATE382053T1 (de) System zur antikörperexpression und- synthese
DK1961811T3 (da) Cytokinligand til behandling af asthma og luftvejs-hyper-responsivitet
BR112012003064B8 (pt) anticorpo ou fragmento de ligação de antígeno do mesmo, combinação que os compreende, método de detecção de infecção por rsv, moléculas de ácido nucléico, e método de produção de um anticorpo ou fragmento de ligação de antígeno do mesmo
ATE517922T1 (de) Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
ATE429445T1 (de) Verfahren zur herstellung von carboxy-terminal amidierten peptiden
EA200901436A1 (ru) Антигенсвязывающие белки, связывающие par-2
EP2631242A3 (de) Verfahren zur Konzentration eines Polypeptids
ATE485517T1 (de) Verfahren zur identifizierung von polypeptid- targets
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
DK200601181A (da) Fiskevaccine
EP2289544A3 (de) Schutzpeptide gegen S. pneumoniae und diesbezügliche Zusammensetzungen, Verfahren und Verwendungen
EP1544293A4 (de) Antikörper gegen ein den von-willebrand-faktor spezifisch spaltendes enzym und assay-system unter verwendung davon
DE602007009116D1 (de) Zusammensetzungen und verfahren zur verabreichung anti-aktivierter ras-antikörper an zellen
MXPA05011085A (es) Composiciones y metodos relacionados a stop-1.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1745297

Country of ref document: EP